Healthcare PharmaceuticalsSingulair
Owned by Unknown Company
Prescription medication for treating asthma and allergies by reducing inflammation in the airways. Originally developed by Merck & Co. and now marketed by Organon & Co. following Merck's 2021 spinoff. Subject to an FDA boxed warning for neuropsychiatric side effects since 2020.
respiratoryasthmaallergies